Cite

HARVARD Citation

    Smith, S. et al. (n.d.). Eligibility for CAR T‐cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL. American journal of hematology. 94 (4), pp. E117-E116. [Online]. 
  
Back to record